Exenatide Acetate API Powder CAS 141758-74-9
Exenatide Acetate
Basisinformation
Exenatide Acetate
CAS: 141758-74-9
Angepasst: Non-Customized
Passend für: Alten, Erwachsene
Reinheit: >99%
Warenzeichen: WuMeiTech
Spezifikation: Qualifiziert
Pulver: Ja
Zustand: Solide
Aussehen: Lyophilized Powder
Transportpaket: According to Your Requirements
Herkunft: China
Hot selling Polypeptide Exenatide Acetate CAS 141758-74-9
Exenatide Product Description
ExenatideA 39-amino acid peptide originally isolated from the salivary glands of the Gila monster (Heloderma suspectum), differs from exendin-3 only in two positions close to the N-terminus. Application of exenatide causes an increase in acinar cAMP without stimulating amylase release.
As an incretin mimetic, exenatide acts as agonist of the glucagon-like peptide-1 (GLP-1) receptor. of diabetes mellitus type 2. Exenatide in its Byetta form is administered as a subcutaneous injection (unter der Haut) of the abdomen, thigh, or arm, any time within the 60 minutes before the first and last meal of the day.
As GLP-1, though with prolonged activity, exenatide augments the postprandial production of insulin and suppresses secretion of glucagon. Aus diesem Grund, exenatide has found use as a medication of diabetes II.
Exenatide Application:
1. Exenatide augments pancreas response and more appropriate amount of insulin that helps lower the rise in blood sugar from eating.
2. Exenatide also suppresses pancreatic release of glucagon, which prevents hyperglycemia (high blood sugar levels).
3. Exenatide helps slow down gastric emptying and thus decreases the rate at which meal-derived glucose appears in the bloodstream.
4. Exenatide has a subtle yet prolonged effect to reduce appetite, promote satiety via hypothalamic receptors.
5. Exenatide reduces liver fat content. Fat accumulation in the liver or nonalcoholic fatty liver disease (NAFLD) is strongly related with several metabolic disorders.
